Tandengoud opbrengst per jaar en enkele transacties
2008 € 850,00
2009 € 6.636,00
2010 € 13.917,00
2011 € 29.830,45
2012 € 31.346,80
2013 € 28.466,53
2014 € 47.924,33
2015 € 38.886,81
2016 € 54.182,00
Totaal: € 250.301,65

DE GELDEN VAN 2015 ACTIES:

Dr. Wilma Mesker, Leiden UMC, 29,900 euro (TESTBREAST study) – transferred 1 feb 2016
Prof. Dr. Paul van Diest, UMC-Utrecht, 30.000 euro
Wilbert Zwart, NKI-AVL, 15.000 euro (gene classifier for tamoxifen success) – transferred 10 dec 2015
Wendy Onstenk, Erasmus MC, 35.000 euro – transferred 1 maart 2016
Dr. Madeleine Tilanus-Linthorst, Erasmus MC, 20.000 euro
Prof. Dr. Tanja de Gruijl, VUmc, 20.000 euro – transferred 1 feb 2016

DE GELDEN VAN 2014 ACTIES:

Dr. Wilma Mesker, Leiden UMC, 50.000 euro (TESTBREAST study) – transferred 8 dec 2014
Prof. Dr. Paul van Diest, UMC-Utrecht, 36.000 euro (Unraveling site-specific metastasis) – transferred 21 november 2014
UPDATE van Diest Moelans(EN & NL) DEC 2015
Prof. Dr. Sabine Linn, NKI-AVL, 50.000 euro (National Breast Cancer Project) – transferred 12 maart en 3 juni 2015
Wilbert Zwart, NKI-AVL, 40.000 euro (gene classifier for tamoxifen success) – transferred 4 mei en 3 juni 2015
Dr. Willemijn Kolff, AMC, 24.000 euro (re-irradiation, locally recurrent breast cancer) – transferred 13 en 19 februari 2015

DE GELDEN VAN 2013 ACTIES:

Prof. Dr. Sabine Linn, NKI-AVL/UMC-Utrecht 68.420 euro (National Breast Cancer Project) – transferred Dec 2013
Prof. dr. Daniel Peeper, NKI 70.000 euro (FRA-1 studies) – transferred Aug 2013
Dr. Michel van Gelder, Maastricht UMC, 19.000 euro (alloreactive NK cell) – transferred Aug 2013
Wendy Onstenk, Erasmus MC, 68.000 euro, (ctc profiling for therapy selection) – transferred 10 januari 2014
Dr. Michael Schaapveld, Dr. Jelle Wesseling, NKI-AVL, 75,000 euro (ipsilateral invasive breast cancer risk) – transferred 22 jan 2014 en 8 mei 2014
Update: Wesseling/Schaapveld (EN)
Sleijfer, Beije (EN)

DE GELDEN VAN 2012 ACTIES:

Dr. Sabine Linn, Karin Beelen, NKI-AVL 153.000 euro (PK13 activation)
Dr. Stefan Sleijfer, Erasmus MC, 60.000 euro (profiling circulating tumor cells)
Prof. dr. Daniel Peeper, NKI 50.000 euro (FRA-1 studies)
Dr. Carina Hilders, UMC-Leiden 50.000 euro (ovarian tissue)
Dr. Tanja de Gruijl, VUMC, 123.000 euro (targeting tumor-induced immune suppression)
Wilbert Zwart, NKI-AVL, 80.000 euro (gene classifier for tamoxifen success)

DE GELDEN VAN 2010 ACTIES:

Dr. Paul van Diest, UMC-Utrecht 210,000 euro (aspirated nipple fluid)
Dr. Sabine Linn, NKI-AVL 150,000 euro (Olaparib, PARP inhibitor)
Dr. Sabine Linn, NKI-AVL 50,000 euro (BRCA-like CGH test)
Prof. dr. Daniel Peeper, NKI 101,000 euro (FRA-1 studies)
Dr. Carina Hilders, UMC-Leiden 50,000 euro (ovarian tissue)
Dr. Sabine Linn, NKI-AVL 37,225 euro (BRCA2-like genomic hybridization classifier)